Related Experiment Video
Updated: Aug 11, 2025
14:22
Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
Published on: July 16, 2011
13.2K
Recent updates of stem cell-based erythropoiesis
Heeju Han1,2, Yeri Alice Rim3, Ji Hyeon Ju4,5
1Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, , Seoul, Republic of Korea.
Human Cell
|February 8, 2023
Summary
Researchers are exploring alternatives to traditional blood transfusions due to donor shortages and disease risks. In vitro erythropoiesis using pluripotent stem cells offers a promising alternative for red blood cell production.
Area of Science:
- Biomedical Science
- Hematology
- Stem Cell Biology
Background:
- Blood transfusions are critical in modern medicine but face limitations like donor scarcity and transfusion-transmitted diseases.
- Recent pandemics highlight the need for alternative therapeutic sources beyond traditional blood donation.
- Existing methods for red blood cell (RBC) production face challenges in scalability and accessibility.
Purpose of the Study:
- To review the fundamental processes of erythropoiesis.
- To examine historical approaches to ex vivo RBC production using hematopoietic stem cells.
- To discuss the current advancements and potential of in vitro erythropoiesis utilizing human-induced pluripotent stem cells (hiPSCs).
Main Methods:
- Review of existing literature on erythropoiesis and stem cell differentiation.
- Analysis of early studies on ex vivo hematopoietic stem cell culture.
- Examination of current research trends in hiPSC-based in vitro erythropoiesis.
Main Results:
- Erythropoiesis involves complex differentiation pathways from stem cells to mature red blood cells.
- Early ex vivo attempts using hematopoietic stem cells showed promise but had limitations.
- In vitro differentiation of hiPSCs represents a significant advancement in generating red blood cells.
Conclusions:
- Human-induced pluripotent stem cells offer a viable and scalable alternative for red blood cell generation.
- In vitro erythropoiesis holds significant potential to overcome limitations associated with traditional blood transfusions.
- Further research into hiPSC-based methods could revolutionize transfusion medicine.
More Related Videos
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
562
06:40Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
Published on: September 9, 2014
15.2K
Related Concept Videos
01:14Erythropoiesis
4.5K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.5K
01:21Hematopoiesis
5.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.5K
01:24Factors Affecting Erythropoiesis
3.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.4K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:19Multipotency of Hematopoietic Stem Cells
3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K